About
Henrik Ahlenius is a Senior Lecturer and Research Team Manager at Lund University's Faculty of Medicine, Department of Experimental Medical Science. He serves as Principal Investigator for multiple prestigious research initiatives including StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, LUCC: Lund University Cancer Centre, and MultiPark: Multidisciplinary research focused on Parkinson's disease.
His research focuses on understanding how aging and neurodegenerative diseases affect the brain, neural cells and neural stem cells. His laboratory utilizes cutting-edge stem cell, reprogramming and genome editing technologies to investigate genetic pathways involved in aging and neurodegenerative disease. Key research areas include developing cellular models of human neuronal aging and degeneration, investigating mechanisms of dysfunction in neurons and neural stem cells in the aging and diseased brain, and studying regulation of normal neurogenesis.
Analysis of his recent publications reveals a strong focus on stem cell models of neurodegenerative diseases, neural differentiation, aging brain mechanisms, and cellular reprogramming approaches. His work spans multiple neurological conditions including Alexander disease, Parkinson's disease, glioblastoma, and general mechanisms of brain aging.
- Senior Lecturer, Research Team Manager
- Principal Investigator, StemTherapy
- Principal Investigator, LUCC
- Principal Investigator, MultiPark
Dr. Ahlenius actively supervises PhD students and has organized major scientific events including UniStem Day 2024. His research has significant implications for understanding and treating neurodegenerative conditions and contributes to UN Sustainable Development Goals related to health and well-being.
